Clinical Trial Update: Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the acceptability and feasibility of extended-release subcutaneous buprenorphine delivered via a mobile pharmacy clinic; status is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Yale University | Conditions: Opioid Use Disorder | Phase 4 | Status: NOT_YET_RECRUITING